The evolution of clinical trials: the pharmaphorum podcastIn the latest episode of the pharmaphorum podcast, Dr Paul Tunnah speaks to head of Patient Engagement at Share XThe evolution of clinical trials: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/the-evolution-of-clinical-trials/
Patient engagement processes: the pharmaphorum podcastThis episode of the pharmaphorum podcast is the second in a limited series focused on patient engagement that’s Share XPatient engagement processes: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/patient-engagement-processes/
Merck on trends in oncology: the pharmaphorum podcastEpisode 45 of the pharmaphorum podcast heard from Dr Stuart Hill, how he’s seen the oncology landscape change Share XMerck on trends in oncology: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/merck-on-trends-in-oncology/
Real-world evidence and qualitative research: the ELICIT podcastIn the first episode of the ELICIT podcast, a new series produced in partnership with Cerner Enviza, the Share XReal-world evidence and qualitative research: the ELICIT podcasthttps://pharmaphorum.com/podcast/real-world-evidence-and-qualitative-research/
Sandoz’s Pierre Bourdage on biosimilars: the pharmaphorum podcastIn the latest episode of the podcast Dominic Tyer speaks with Pierre Bourdage, who’s global head of biopharmaceuticals Share XSandoz’s Pierre Bourdage on biosimilars: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/sandozs-pierre-bourdage-on-biosimilars/
Patient engagement strategies: the pharmaphorum podcastThis episode of the pharmaphorum podcast is the first in an occasional series focused on patient engagement that’s Share XPatient engagement strategies: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/patient-engagement-strategies/
BMS’ Catherine Owen on pharma commercialisation: the pharmaphorum podcastEpisode 42 of the pharmaphorum podcast heard from Catherine Owen, who’s senior vice president of major markets at Share XBMS’ Catherine Owen on pharma commercialisation: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/bms-catherine-owen-pharma-commercialisation/
Novartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcastEpisode 41 of the pharmaphorum podcast heard from Amit Nastik about the impact of COVID-19 on pharma supply Share XNovartis’ Amit Nastik on COVID’s supply chain impact: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/novartis-amit-nastik-pharma-supply-chain/
Virtual engagement and collaborations: the pharmaphorum podcastAs the world passes the year and a half mark of the COVID-19 pandemic, the evolving ‘new normal’ Share XVirtual engagement and collaborations: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/virtual-engagement-impetus-digital/
